CUV 0.00% $14.30 clinuvel pharmaceuticals limited

investors are angry , page-7

  1. 648 Posts.
    rvbird,

    I couldn't agree more. The red flag for me was when the board had shareholders vote on a raise in compensation for Wolgen a couple years ago when long-term shareholders were significantly in the red.

    Think about - Wolgen gets his raise - and the company was running out of cash a few years later.

    Another reason why I sold a lot of shares. That kind of stuff is outrageous to me.

    Far too much compensation for a company that needed more cash.

    I ask again what shareholders were thinking when they voted to increase Wolgen's compensation. I know many who were very angry about this and voted against it.
 
watchlist Created with Sketch. Add CUV (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.